Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying the use of transcranial direct current stimulation tDCS to help patients with Long Covid who suffer from symptoms such as headaches, migraines, chronic pain including arthralgia and myalgia, and sleep problems. This treatment is common in physiotherapy and rehabilitation and has shown promising results for symptoms similar to those experienced by Long Covid patients. The study aims to verify whether tDCS can be effective for these patients despite differences in symptom origins. The study includes an initial phase where participants with Long Covid receive anodal tDCS, followed by an extended randomized, double-blind, sham-controlled phase. Participants are assigned to one of four groups anodal, bifrontal, cathodal, or sham tDCS, with all groups receiving the same number of sessions and stimulation intensity. The tDCS treatment involves applying a low electrical current through surface electrodes on the scalp for 2030 minutes per session over about 20 consecutive sessions. Participants undergo various assessments before, immediately after, and up to six months following treatment. These include evaluations of chronic body pain, migraine or headache intensity, quality of life, mood, and sleep quality using questionnaires and brain resilience measured by EEG-TMS. The study monitors participants closely through these time points to understand the effects of the therapy and any changes in symptoms over time.